AGF Investments Inc. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 490,734 shares of the healthcare conglomerate’s stock after selling 10,266 shares during the quarter. UnitedHealth Group makes up 1.0% of AGF Investments Inc.’s investment portfolio, making the stock its 21st largest position. AGF Investments Inc.’s holdings in UnitedHealth Group were worth $91,015,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp grew its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Veritas Asset Management LLP grew its holdings in shares of UnitedHealth Group by 8.2% during the second quarter. Veritas Asset Management LLP now owns 5,291,867 shares of the healthcare conglomerate’s stock worth $981,218,000 after buying an additional 399,878 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of UnitedHealth Group by 2.6% during the second quarter. Legal & General Group Plc now owns 5,085,698 shares of the healthcare conglomerate’s stock worth $943,004,000 after buying an additional 131,006 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after buying an additional 681,111 shares in the last quarter. Finally, Harris Associates L P grew its holdings in shares of UnitedHealth Group by 0.3% during the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares in the last quarter. Institutional investors and hedge funds own 86.17% of the company’s stock.
In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. In the last 90 days, insiders sold 72,149 shares of company stock valued at $14,212,342. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.07 on Monday. UnitedHealth Group Incorporated has a 12-month low of $146.01 and a 12-month high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.72 and a current ratio of 0.70. The company has a market cap of $204,080.00, a price-to-earnings ratio of 21.99, a PEG ratio of 1.57 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.17 earnings per share. research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.
COPYRIGHT VIOLATION WARNING: “AGF Investments Inc. Sells 10,266 Shares of UnitedHealth Group Incorporated (UNH)” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2017/11/13/agf-investments-inc-sells-10266-shares-of-unitedhealth-group-incorporated-unh.html.
Several research firms recently issued reports on UNH. Cantor Fitzgerald reissued an “overweight” rating and issued a $208.00 target price on shares of UnitedHealth Group in a research report on Friday, July 21st. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, BidaskClub cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $216.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.